Literature DB >> 17639650

Modified directly observed therapy for antiretroviral therapy: a primer from the field.

Kathy Goggin1, Robin J Liston, Jennifer Adelson Mitty.   

Abstract

Modified directly observed therapy (mDOT), in which a portion of total doses of a medication regime is ingested under supervision, has demonstrated efficacy as an intervention to assist patients in maintaining adherence to complicated antiretroviral therapy (ART). Although findings are favorable, existing efficacy studies fail to provide sufficient detail to guide others who wish to implement mDOT interventions. The aim of this article is to provide a primer for practitioners and researchers who wish to implement mDOT interventions. Drawing on the experience of 10 federally funded research projects, we provide guidance on critical questions for program implementation, including: who should be targeted, length/duration/content/location/tapering of sessions, staffing, incentives, and approaches to data collection. In addition, guidance on staff training and minimum requirements for mDOT interventions is offered along with real-world examples of mDOT interventions. mDOT is feasible and easily adapted to many settings and target populations. Interventions should match the specific needs of the target population and setting and be flexible in terms of design and delivery. mDOT should be considered among the spectrum of adherence interventions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17639650      PMCID: PMC1888521          DOI: 10.1177/003335490712200408

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  26 in total

1.  A meta-analytic review of experiments examining the effects of extrinsic rewards on intrinsic motivation.

Authors:  E L Deci; R Koestner; R M Ryan
Journal:  Psychol Bull       Date:  1999-11       Impact factor: 17.737

2.  Directly observed therapy in HIV therapy: A realistic perspective?

Authors:  M Lanzafame; M Trevenzoli; A M Cattelan; P Rovere; A Parrinello
Journal:  J Acquir Immune Defic Syndr       Date:  2000-10-01       Impact factor: 3.731

3.  Directly observed therapy to treat HIV infection in prisoners.

Authors:  S Babudieri; A Aceti; G P D'Offizi; S Carbonara; G Starnini
Journal:  JAMA       Date:  2000-07-12       Impact factor: 56.272

4.  Pervasive negative effects of rewards on intrinsic motivation: The myth continues.

Authors:  J Cameron; K M Banko; W D Pierce
Journal:  Behav Anal       Date:  2001

5.  A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

Authors:  S M Hammer; K E Squires; M D Hughes; J M Grimes; L M Demeter; J S Currier; J J Eron; J E Feinberg; H H Balfour; L R Deyton; J A Chodakewitz; M A Fischl
Journal:  N Engl J Med       Date:  1997-09-11       Impact factor: 91.245

6.  Improving on success: what treating the urban poor in America can teach us about improving antiretroviral programmes in Africa.

Authors:  Anthony Amoroso; Derek E Spencer; Robert R Redfield
Journal:  AIDS       Date:  2004-06       Impact factor: 4.177

7.  Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection.

Authors:  Sue J Goldie; A David Paltiel; Milton C Weinstein; Elena Losina; George R Seage; April D Kimmel; Rochelle P Walensky; Paul E Sax; Kenneth A Freedberg
Journal:  Am J Med       Date:  2003-12-01       Impact factor: 4.965

8.  Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

Authors:  A Mocroft; S Vella; T L Benfield; A Chiesi; V Miller; P Gargalianos; A d'Arminio Monforte; I Yust; J N Bruun; A N Phillips; J D Lundgren
Journal:  Lancet       Date:  1998-11-28       Impact factor: 79.321

9.  Preliminary findings of an intervention integrating modified directly observed therapy and risk reduction counseling.

Authors:  C G Mitchell; S Freels; C M Creticos; A Oltean; R Douglas
Journal:  AIDS Care       Date:  2007-04

10.  Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients.

Authors:  R W Shafer; M A Winters; S Palmer; T C Merigan
Journal:  Ann Intern Med       Date:  1998-06-01       Impact factor: 25.391

View more
  16 in total

Review 1.  Adherence to biomedical HIV prevention methods: considerations drawn from HIV treatment adherence research.

Authors:  Michael J Stirratt; Christopher M Gordon
Journal:  Curr HIV/AIDS Rep       Date:  2008-11       Impact factor: 5.071

Review 2.  The role of prospective memory in medication adherence: a review of an emerging literature.

Authors:  Jennifer B Zogg; Steven Paul Woods; John A Sauceda; John S Wiebe; Jane M Simoni
Journal:  J Behav Med       Date:  2011-04-13

3.  Dispensation of antiretroviral therapy and methadone maintenance therapy at the same facility in a low-barrier setting linked to optimal adherence to HIV treatment.

Authors:  N A Mohd Salleh; N Fairbairn; S Nolan; R Barrios; J Shoveller; L Richardson; M-J Milloy
Journal:  HIV Med       Date:  2019-07-29       Impact factor: 3.180

Review 4.  Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review.

Authors:  Jessica E Hart; Christie Y Jeon; Louise C Ivers; Heidi L Behforouz; Adolfo Caldas; Peter C Drobac; Sonya S Shin
Journal:  J Acquir Immune Defic Syndr       Date:  2010-06       Impact factor: 3.731

5.  Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: a randomized controlled trial.

Authors:  Karina M Berg; Alain Litwin; Xuan Li; Moonseong Heo; Julia H Arnsten
Journal:  Drug Alcohol Depend       Date:  2010-09-15       Impact factor: 4.492

6.  Peer knowledge and roles in supporting access to care and treatment.

Authors:  Carol R Tobias; Serena Rajabiun; Julie Franks; Sarah B Goldenkranz; David N Fine; Brenda S Loscher-Hudson; Paul W Colson; Sharon M Coleman
Journal:  J Community Health       Date:  2010-12

7.  Cost of behavioral interventions utilizing electronic drug monitoring for antiretroviral therapy adherence.

Authors:  Rafia S Rasu; David F Malewski; Julie W Banderas; Domonique Malomo Thomson; Kathy Goggin
Journal:  J Acquir Immune Defic Syndr       Date:  2013-05-01       Impact factor: 3.731

8.  A qualitative examination of the indirect effects of modified directly observed therapy on health behaviors other than adherence.

Authors:  Andrea Bradley-Ewing; Domonique Thomson; Megan Pinkston; Kathy J Goggin
Journal:  AIDS Patient Care STDS       Date:  2008-08       Impact factor: 5.078

9.  Strategies for promoting adherence to antiretroviral therapy: a review of the literature.

Authors:  Jane M Simoni; K Rivet Amico; Cynthia R Pearson; Robert Malow
Journal:  Curr Infect Dis Rep       Date:  2008-11       Impact factor: 3.725

10.  Development of a directly observed therapy adherence intervention for adolescents with human immunodeficiency virus-1: application of focus group methodology to inform design, feasibility, and acceptability.

Authors:  Patricia A Garvie; Joanne Lawford; Patricia M Flynn; Aditya H Gaur; Marvin Belzer; George D McSherry; Chengcheng Hu
Journal:  J Adolesc Health       Date:  2008-10-18       Impact factor: 5.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.